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Lens opacity 11 (lop11) is an autosomal recessive mouse cataract mutation that arose spontaneously in the RIIIS/J strain. At 3 weeks of age
mice exhibit total cataracts with vacuoles. The lop11 locus was mapped to mouse chromosome 8. Analysis of the mouse genome for the lop11
critical region identified Hsf4 as a candidate gene. Molecular evaluation of Hsf4 revealed an early transposable element (ETn) in intron 9 inserted
61 bp upstream of the intron/exon junction. The same mutation was also identified in a previously mapped cataract mutant, ldis1. The ETn
insertion altered splicing and expression of the Hsf4 gene, resulting in the truncated Hsf4 protein. In humans, mutations in HSF4 have been
associated with both autosomal dominant and recessive cataracts. The lop11 mouse is an excellent resource for evaluating the role of Hsf4 in
transparency of the lens.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cataracts; Mouse; Mapping; Locus; Gene; Mutation; Transposon; Insertion; Hsf4; ExpressionCataracts are the most frequent cause of treatable blindness
worldwide [1], with the majority of cataracts occurring in the
elderly [2]. Congenital cataracts, though significantly less
common than age-related cataracts, are the leading cause of
treatable childhood blindness [3]. The incidence of congenital
cataracts has been estimated to vary from 0.6 to 6 per 10,000
live births [4], of which about half are hereditary [5]. The
identification of genes harboring mutations responsible for
hereditary congenital cataracts facilitates a better understanding
of the initial molecular events in cataractogenesis, including
novel insights into the mechanisms responsible for the
development and function of the lens. Mutations in at least 19
genes have been identified as associated with human hereditary
congenital cataracts [4].
Mice are excellent animal models for gene discovery and
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doi:10.1016/j.ygeno.2006.02.012ment of cataracts. More then 60 mouse cataract models have
been recovered either from large-scale mutagenesis projects or
as a result of spontaneous mutations identified in breeding
colonies [6]. Controlled breeding and large litter size have
allowed for efficient mapping and cloning of mutations in a
number of cataract-associated genes [6]. In addition, the
mouse cataract models provide excellent tissue resources for
detailed evaluation of the phenotype, as well as the
differential expression of candidate genes by age, tissue, or
disease status. Mouse cataract models are of great benefit in
understanding molecular pathways relevant for the transpar-
ency of the lens.
In both humans and mice, the majority of mutations
responsible for congenital cataracts show autosomal dominant
inheritance. However, significant progress has been made in
families with autosomal recessive congenital cataracts for which
mutations in five genes, LIM2 [7], CRYAA [8], HSF4 [9,10],
GCNT2 [11], and CRYBB3 [12], have been identified. In mouse
models, mutations in only two genes, Cryaa [13] and Crygs
Fig. 1. Histological sections of P21 mouse lenses. (A) lop11/lop11 shows the presence of vacuoles throughout the lens. (B) lop11/+ shows no pathological changes.
Fig. 2. Chromosomal mapping of the lop11 locus. (A) Each column represents
the haplotype identified in the backcross progeny: (n) CAST/E allele, (□)
RIIIS/J allele. The number of offspring inheriting each type of chromosome is
listed at the bottom of each column. (B) Linkage map of the lop11 locus; the
numbers on the left represent the genetic distances in centimorgans (cM).
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genital cataracts. Therefore, more insight is needed to under-
stand the genes and molecular/cellular processes that lead to
recessive congenital cataracts.
The focus of this study is on a mouse model of recessive
congenital hereditary cataracts that arose spontaneously in the
RIIIS/J strain. The cataract locus was termed lens opacity 11
(lop11). Here we present mapping and cloning of the lop11
locus. Further analysis identified the insertion of an early
transposable element in intron 9 of the Hsf4 gene that altered
splicing and expression of the Hsf4 gene and resulted in
truncated Hsf4 protein. The same Hsf4 transposon insertion
identified in lop11 was also identified in the ldis1 mouse
cataract locus that had previously been mapped to mouse
chromosome 8 [15]. The Hsf4 gene belongs to a family of
highly conserved heat shock transcription factors. Mutations in
HSF4 have been identified in families with both autosomal
dominant [16] and recessive congenital cataracts [9,10].
However, it remains unknown how mutations in HSF4 lead to
cataractogenesis. The lop11 mice offer a valuable resource
for evaluation of the role of Hsf4 in the lens and molecular
mechanisms that lead to cataract development in both humans
and mice.
Results
The slit lamp examination of the cataract-affected adult
RIIIS/J mouse, termed lens opacity 11 (lop11), showed diffuse
cortical and nuclear opacification with white vacuoles
irregularly patterned throughout the lens. All portions of the
lens were affected. The fundus could not be seen due to the
lens opacity. Lids, cornea, and iris were all unremarkable and
media was clear. The cataract phenotype in lop11 mice seg-
regated as an autosomal recessive trait. These data were
confirmed by (lop11/lop11 × CAST/E)F1 × lop11/lop11 back-
cross. Clinical examination of the affected F2 lop11/lop11
mice showed cataracts identical to those of the parental lop11/
lop11 phenotype. The F2 lop11/lop11 histological examination
was consistent with the clinical observations that the lens
structure showed vacuoles and extensive disorganization (Fig.
1A). In contrast, F2 lop11/+ showed the wild-type phenotype
(Fig. 1B), consistent with the autosomal recessive mode of
inheritance.Genome-wide segregation analysis identified linkage
between the lop11 locus and microsatellite markers on chro-
mosome 8. The lop11 locus was mapped further between
D8Mit110 and D8Mit313; no recombinants were identified
with marker D8Mit198 (Fig. 2). Evaluation of the mouse
genome map (http://genome.ucsc.edu/cgi-bin/hgGateway) of
the lop11 critical region identified heat shock transcription
factor 4 (NM_011939). To evaluate Hsf4 as a candidate
gene, we generated RT-PCR products from whole eye
mRNA from postnatal day 21 (P21) lop11/lop11 and wild-
type C57BL/6 mice. RT-PCR from lop11/lop11 mRNA
with primers specific to Hsf4 exons 1 through 6 generated
cDNA products identical to the product from C57BL/6
(NM_011939) (Fig. 3A) and from exons 3 through exon 9
(data not shown). The identities of PCR products were
confirmed by sequencing. However, RT-PCR with primers
specific for Hsf4 exons 10 through 13 did not yield any
cDNA products in lop11/lop11. In contrast, mRNA from
C57BL/6 produced cDNAs of the expected size (Fig. 3A).
Northern blot analysis of the Hsf4 expression in wild-type
Fig. 3. RT-PCR and Northern blot analysis. (A) Acrylamide gel electrophoresis
of RT-PCR products derived from amplification of theHsf4 gene frommouse eye
mRNA.AnRT-PCR product encompassing exons 1–6 is present in C57BL/6 and
lop11/lop11 (lanes 1 and 2). An RT-PCR product encompassing exons 10–13 is
present in C57BL/6, but absent from lop11/lop11 (lanes 4 and 5). Lanes 3 and 6
showH2O as a negative control; lane 7 is theϕχ-174 RF DNAHaeIII molecular
weight marker. (B) Northern analysis from P21 and P1 C57/BL6 and lop11/lop11
whole eye mRNA hybridized with a 5′ endHsf4 probe (exons 1–6). Arrow to the
left points to the wild-typeHsf4 transcript. Arrow to the right points to the lop11–
Hsf4 transcript of the smaller molecular weight and higher level of expression.
Hybridization of the same blot withGapdh shows even loading between samples.
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the RT-PCR data. Hybridization with a 3′ end Hsf4 cDNA
failed to detect the Hsf4 transcript in P21 and P1 lop11/lop11Fig. 4. The analysis of the lop11 allele. (A) Southern blot analysis of the Hsf4 region.
the 3′ end Hsf4 cDNA probe (exons 10–13). (B) LR-PCR spanning Hsf4 intron 9 sh
(lane 4) λ HindIII marker. (C) Structure of the lop11 allele. Partial genomic sequen
represent the primers used to amplify across the insertion in (B). Highlighted in gra
transposable element (Accession No. Y17106) placed in the 5′ → 3′ orientation −
sequence traces from the chimeric Hsf4–ET cDNA showing alternative splicing betw
separates the 3′ end of Hsf4 exon 9 and the 5′ of the pseudo-exon from the ETnII emouse eyes (data not shown). However, hybridization of the
same Northern blot with the 5′ end Hsf4 cDNA identified in
lop11/lop11 an Hsf4 transcript of smaller molecular weight
more abundantly expressed compared to the wild-type Hsf4
expressed in C57BL/6. This higher level of expression of the
Hsf4 transcript was shown to be present in both P21 and P1
lop11/lop11 eye tissues (Fig. 3B).
Genomic differences in the Hsf4 region between lop11/+
and lop11/lop11 were identified via Southern blotting
(Fig. 4A). To determine if these differences were due to
polymorphisms between RIIIS/J and CAST/E strains or
genomic differences responsible for the cataract phenotype,
we initiated sequencing of the Hsf4 genomic region. Our
analysis did not detect any sequence difference between
lop11/lop11 and C57BL/6 in any of the 13 exons, 650 bp
upstream of the start codon, or any of the introns, except the
3′ end of intron 9. Initially, the conventional PCR did not
yield a product from the 3′ end of intron 9 for lop11/lop11.
However, long-range PCR in lop11/lop11 generated a PCR
product about 5.6 kb larger than in C57BL/6 (Fig. 4B) and
CAST/Ei (data not shown). Sequencing of the 5.9-kb PCR
product from lop11/lop11 revealed an insertion of 5542 bp
positioned −61 bp upstream of the 5′ intron/exon junction of
exon 10. The Blast analysis of the 5542-bp inserted sequence
revealed it to be identical to an early transposable ele-
ment (ETn) (Accession No. Y17106) (Fig. 4C). The ETn
insertion cosegregated with all affected F2 lop11/lop11
progeny. All the unaffected lop11/+ were heterozygous for
the ETn insertion. Neither C57BL/6 nor CAST/Ei strains
contained the ETn insertion in intron 9 of Hsf4. To det-
ermine if ETn was responsible for aberrant splicing of Hsf4,
RT-PCR was performed with primers specific for Hsf4
and the ETn sequence (Accession No. Y17106). A chimeric
transcript showing aberrant splicing between Hsf4 exon
9 and the pseudo-exon starting at 21 bp of the ETn se-
quence Accession No. Y17106) was identified (Fig. 4D).
The sequence analysis of the Hsf4–ET transcript identified
an open reading frame of 1059 bp following a premature
stop codon.
To determine if the ETn insertion had any consequences on
the Hsf4 protein in lenses of lop11/lop11, we performedWestern
blots. The Hsf4 protein was identified as an Hsf4-immunore-
active band of about 55 kDa in protein extracts from lenses of
C57BL/6 (Fig. 5) that comigrated with a band from Jurkat cell
lysates (data not shown) that served as a positive control.
However, the 55-kDa Hsf4 was absent in protein extracts from
lop11/lop11, but an Hsf4-immunoreactive band of about 40 kDa
was identified that was not present in C57BL/6 (Fig. 5). In
contrast to the observation on the Northern blot, on the Western
blot the 40-kDa Hsf4 mutant band did not appear to beHindIII- and PstI-digested DNA from lop11/+ and lop11/lop11 hybridized with
owing the ETn insertion: (lane 1) lop11/lop11, (lane 2) C57BL/6, (lane 3) H2O,
ce of the chimeric Hsf4–ET genomic DNA from lop11 mice. Boxed sequences
y is exon 10. The 5542-bp inserted sequence is the perfect match of the ETnII
61 bp downstream of the 5′ intron/exon junction of exon 10. (D) Fluorescent
een Hsf4 exon 9 and the pseudo-exon from the ETn insertion. The dashed line
lement (Accession No. Y17106).
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Fig. 5. Western blot analysis of protein from P21 mouse lenses from C57BL/6
and lop11/lop11. (A) Western blot using antibody specific to Hsf4; the arrow
on the left points to the wild-type Hsf4 protein of about 55 kDa and the
arrow on the right points to truncated Hsf4 of about 40 kDa. (B) Western blot
using antibody specific for β-actin; the arrow points to the 43-kDa β-actin
band.
48 E. Talamas et al. / Genomics 88 (2006) 44–51expressed at a higher level compared to the 55-kDa Hsf4
protein.
Following mapping of the lop11 locus, a search of MGI
(http://www.informatics.jax.org) identified that another reces-
sive mouse cataract locus, ldis1, maps to chromosome 8 [15]
close to lop11. The ldis1 locus was also identified in the RIIIS/J
strain. Comparison of the clinical phenotype between lop11 and
ldis1 revealed similar cataracts in both strains. Based on the
same strain origin and phenotypical and genetic similarities, we
hypothesized that ldis1 may carry the same mutation as lop11.
Long-range PCR and sequence analysis of ldis1/ldis1 identified
the same 5542-bp ETn (Accession No. Y17106) sequence in
intron 9 inserted −61 bp upstream of the 5′ intron/exon junction
of exon 10 as already identified in lop11.
Discussion
In this study we have shown that the Hsf4 gene in lop11
mice carries the insertion of an early transposable element in
intron 9. Following mapping of the lop11 locus, a search of
MGI (http://www.informatics.jax.org) identified another reces-
sive mouse cataract mutant termed “lens disrupter 1” (ldis1).
This ldis1 locus was in the RIIIS/J strain that was originally
obtained from The Jackson Laboratory and subsequently
diagnosed for cataracts [15]. Independent of findings on the
ldis1 strain, the lop11 strain was identified during systematic
screening of mutant and inbred strains for eye defects at The
Jackson Laboratory. Sequencing of Hsf4 intron 9 identified the
same ETn insertion in ldis1 mice that was found for lop11.
Based on the same RIIIS/J strain origin, and similar clinical,
genetic, and molecular data, we believe that lop11 and ldis1
are a single mutation that arose spontaneously only once in
RIIIS/J. Although we did not set up allelic crosses between
ldis1 and lop11 that would unequivocally prove that these two
lines are mutations in the same gene, we conclude that
cataracts in both lop11 and ldis1 are due to the same Hsf4–
ETn insertion.
ETn elements are a family of repetitive sequences tran-
scribed during early mouse embryogenesis, primarily inundifferentiated cells of the inner cell mass and embryonic
ectoderm [21]. They range in length from 4.4 to 7.1 kb and lack
significant open reading frames [22]. ETn elements have long
terminal repeat (LTR) sequences and have been classified into
two groups (ETnI and ETnII), which differ only in the 3′ half of
the LTR and in the 5′ end of the internal region [22]. The
mutagenic power of ETn elements has been established with at
least 14 mouse mutations that are due to ETn insertions [22],
resulting in various phenotypes, including cataracts. An ETn
insertion in the Mip gene in the CatFr mouse resulted in
congenital cataracts [23]. The 5542-bp ETn element (Accession
No. Y17106) identified in this study as inserted into Hsf4 intron
9 belongs to an ETII family of early transposable elements. The
same ETnII element (Accession No. Y17106) was responsible
for mutagenesis in SELH/Bc mice in the Tyr gene resulting in
the albino phenotype [24].
Our ability to detect Hsf4 mRNA fragments from exons 1
through 9 indicated that the lop11–Hsf4 locus remained
transcriptionally active despite the presence of the transposon.
However, the full-length wild-type Hsf4mRNAmolecule could
not be detected by RT-PCR or Northern blot in lop11. We
identified a product of alternative splicing between Hsf4 exon 9
and a pseudo-exon in the transposon sequence resulting in
premature termination. The open reading frame of the chimeric
Hsf4–ET transcripts predicts the chimeric Hsf4–ETn protein to
be composed of 353 amino acids (aa), with 330 aa originating
from the Hsf4 gene (exons 1 through 9) and 23 aa from the
transposon pseudo-exon. The predicted molecular weight of this
chimeric protein would be 38.69 kDa (http://www.sciencegate-
way.org/tools/proteinmw.htm). Western blots identified an
Hsf4-immunoreactive band of about 40 kDa in lop11, further
supporting these findings. We could not detect the wild-type 55-
kDa Hsf4 protein as present in lop11 lenses; thus we conclude
that the ETn insertion is responsible for the cataract phenotype
in the lop11 mouse.
It has been shown that the functional Hsf4 protein is
essential for maintenance of lens transparency. Knockout
studies demonstrate that Hsf4 expression in the developing
lens is required for correct lens development [25,26]. In
families with autosomal dominant lamellar and Marner
cataracts four different missense mutations have been
identified within the HSF4 DNA binding domain [16]. In
addition, a splice mutation causing skipping of exon 12 was
identified in a family with autosomal recessive cataracts [9].
Recently, two additional mutations, R175P and a frameshift
mutation (595_599delGGGCCC), were reported in families
with autosomal recessive cataracts [10]. These studies support
the critical role of the functional Hsf4 protein for the
physiology of the lens.
The role of Hsf4 in the lens has been proposed as a
transcriptional regulator of genes necessary for proper lens
development. In rat lenses Hsf4 was shown to have a spe-
cific interaction with αB-crystallin [27]. Expression profiles
previously reported from adult ldis1 mouse whole eyes
showed down regulation of γ-crystallins, transforming growth
factor, fibroblast growth factor, the bone morphogenic pro-
teins, and the activins [15]. Expression profiles from Hsf4
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crystallin genes and regulates expression of growth factor
genes essential for cell growth and differentiation [26]. Our
findings point to another possible role for Hsf4. The truncated
lop11–Hsf4 transcript identified in lop11/lop11 lenses was
more abundant than the wild-type Hsf4 detected in C57BL/6
lenses. Given that the wild-type Hsf4 is absent in lop11, it is
possible that the functional Hsf4 protein may participate in
negative self-regulation of expression. However, we cannot
exclude a possibility that the ETn integration increases the
stability of the truncated lop11–Hsf4 transcript or that the ETn
integration up regulates expression of the lop11–Hsf4
transcript resulting in the more abundant truncated Hsf4
transcript. Regardless of the mechanism responsible for the
more abundant chimeric Hsf–ET transcript, we did not ob-
serve higher levels of the mutant Hsf4 protein (Fig. 5). These
findings suggest that the mutant Hsf4 protein likely undergoes
a degradation process.
In the lop11 mouse the absence of the wild-type Hsf4
protein is consistent with the cataract phenotype. At this
point it is unclear if cataracts in lop11 are due only to the
absence of functional Hsf4 protein and its transcriptional
regulation of essential lens genes such as crystallins and
growth factors. Alternatively, cataracts may be due to an
inability of the lens to degrade the truncated Hsf4 protein
fully, ultimately resulting in cellular cytotoxicity and
compromised processing of other lens proteins. Further
studies are needed to elucidate the role of the ETn insertion
in the Hsf4 gene as it relates to the onset of cataracts in lop11
mice.
It should be noted that Hsf4 has been reported to exist as
at least two isoforms, Hsf4a and Hsf4b, due to two alternative
splice sites in exons 8 and 9 [28,29]. Two distinct roles have
been proposed for the two Hsf4 isoforms: Hsf4a as a tran-
scription suppressor and Hsf4b, which contains 30 additional
amino acids, as a transcription activator. In human and mouse
lenses only Hsf4b transcript has been identified [25,26].
Our study also identified only the Hsf4b transcript as pre-
sent in the lens. The Hsf4–ETn insertion identified in lop11
probably affects splicing of both Hsf4a and Hsf4b; we eval-
uated consequences of the ETn insertion only for the Hsf4b
transcript and protein in the lens. However, we have not
evaluated the expression of Hsf4b in brain, lung, liver, and
skeletal muscle [29] or the expression of Hsf4a in brain,
heart, skeletal muscle, and pancreas [28]. The effects of the
ETn insertion on expression of Hsf4a and Hsf4b in other
tissues, and if the ETn insertion may be responsible for
phenotypes other then cataracts reported for the RIIIS/J strain
(http://www.informatics.jax.org), are beyond the scope of this
study.
Materials and methods
lop11 identification
Inbred mouse strains were systematically screened for any eye defects with a
slit lamp and indirect ophthalmoscope as previously described [17]. The inbred
strain RIIIS/J showed complete cataracts and was further evaluated.Linkage mapping
The lop11/lop11 mice were outcrossed to CAST/Ei, and F1 mice were
backcrossed to lop11/lop11 to generate 145 backcross progeny. The progeny
were evaluated at 3 weeks of age with a slit lamp following mydriasis with 1%
atropine, and phenotypes were recorded. The animals were euthanized and
tissues were collected. For linkage analysis, genomic DNA was isolated from
spleens and typed with polymorphic markers as described previously [18].
Briefly, the initial genome-wide scan was performed using DNA from 25 F2
backcross progeny and 51 polymorphic microsatellites. The markers were
selected about 30 cM apart across mouse autosomes [18]. Once linkage to
chromosome 8 was established, additional markers from chromosome 8 were
selected and all 145 F2 backcross progeny were typed.
Histology
Whole eyes were fixed in 4% paraformaldehyde in phosphate-buffered
saline for 24 h, dehydrated for 20 min through increasing concentrations (50, 75,
and 95%) of ethanol, paraffin embedded, serially sectioned (5 μm), and stained
with hematoxylin and eosin.
Hsf4 exon scanning
Genomic PCR was carried out in 25-μl volumes containing 100 ng
genomic DNA, a 0.2 mM concentration of each primer, a 0.315 mM
concentration of each dNTP, 10 mM Tris–HCl (pH 8.3), 50 mM KCl,
1.5 mM MgCl2, 0.625 U Taq polymerase (Invitrogen, Carlsbad, CA, USA).
Reactions were carried out as follows: 95°C (3 min); 30 cycles of 95°C
(30 s), annealing temperature as indicated in Table 1 (30 s), 72°C (30 s); final
extension 72°C (7 min). Primer sequences are summarized in Table 1. PCR
products were electrophoresed on 6% acrylamide gels, stained with ethidium
bromide, photographed, and purified with Microcon centrifugal filter devices
(Millipore, Billerica, MA, USA). The resultant PCR products were sequenced
directly with the AmpliTaq FS sequencing kit (Applied Biosystems, Foster
City, CA, USA), and sequencing analysis was done with the ABI 310 genetic
analyzer. Comparative sequence analysis was done with DNAStar software
(Madison, WI, USA).
RT-PCR and Northern blot
Total RNAwas isolated from whole P21 and P1 eyes using TRIzol reagent
(Invitrogen) and was electrophoresed (20 μg/lane), blotted, and hybridized
following a standard protocol [18]. RT-PCR was performed as previously
described [19] using primers summarized in Table 1. For hybridization, the 5′
end of the Hsf4 cDNA was generated via RT-PCR from C57BL/6 mouse eyes
using primers from Table 1. To generate an RT-PCR product of the alternatively
spliced Hsf4–ET cDNA primers were selected to anneal in Hsf4 exon 9 and
ETnII (Accession No. Y17106) as indicated in Table 1. As a control a
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) partial cDNA probe was
generated via RT-PCR from C57BL/6 mouse kidneys using primers 5′-
TGAAGGTCGGTGTGAACGGATTTGGC-3′ and 5′-CATGTAGGCCAT-
GAGGTCCACCAC-3′. The probe was radiolabeled with [α-32P]dCTP
(Amersham Biosciences, Piscataway, NJ, USA) using the Random Primed
DNA Labeling Kit (Invitrogen) following the manufacturer's protocol. For each
subsequent hybridization the probe was stripped and rehybridized as described
previously [19].
Southern blot and long-range PCR (LR-PCR)
Genomic DNA (10 μg) from lop11/+ and lop11/lop11 was digested with
HindIII and PstI, electrophoresed on 0.9% agarose, blotted, and hybridized as
described previously [19]. The 3′ end Hsf4 cDNA probe was RT-PCR generated
(Table 1) and radiolabeled with [α-32P]dCTP (Amersham Biosciences) using the
Random Primed DNA Labeling Kit (Invitrogen) following the manufacturer's
protocol. For LR-PCR primers were designed to amplify a region in Hsf4 intron
9 (Table 1). LR-PCR was performed using the GeneAmp kit (Applied
Biosystems). The reactions were carried out in 100-μl volumes containing
Table 1
PCR primers used to amplify genomic and cDNA segments of Hsf4
Target Primer name Primer sequence (5′–3′) Annealing temperature (°C)
HSF4 exon 1 HSF4 1 F CACTTTCGCGGCTTTGAC 60
HSF4 1.1 R TCTCCCCATCTTTGCTTCAC
HSF4 intron 1 HSF4 Intron 1 F CCTCAACTCCTTCAGTGGTC 60
HSF4 Intron 1 R TCACTTACGAGGAAGCTGGT
HSF4 exons 2–4 HSF4 2 F TGGACCCCCACAGTGAGTAT 65
HSF4 2 R GAGGCTCCAACCAAAGAGC
HSF4 exons 5–6 HSF4 3.1 F GTATCCCCTTGCTGGCAAC 63
HSF4 3 R CTGGAGGGTCTTTGGATGTG
HSF4 intron 6 HSF4 Intron 6 F GTGGTGTTGACACCTGCAT 60
HSF4 Intron 6 R CATTGAATTTGGCAGATGCT
HSF4 exon 7 HSF4 4.1 F TTCCACTCCAGCATGTGACT 62
HSF4 4.1 R CTAGGTCTGGGTGGTCGAGT
HSF4 intron 7 HSF4 Intron 7 F CCTCCAGGACCCCTACTTTA 60
HSF4 Intron 7 R CCTGTGTCCTTCAGGAGATG
HSF4 exon 8 HSF4 5 F CCCAGCACAGATCATTTTCA 60
HSF4 5 R TGCACCAGAGAAAAGCTTCA
HSF4 intron 8 HSF4 Intron 8 F CTGAAGGACACAGGCTTTCT 60
HSF4 Intron 8 R CTGTAGCTCCCTTTCCCTTC
HSF4 exon 9 HSF4 6 F AAAGAAGAGCCGGCCAGT 62
HSF4 6 R AGCTGCCTCAGGACCATAAA
HSF4 intron 9 HSF4 Intron 9 F TGTACAACAGCCTGAACCAA 60
HSF4 Intron 9 R TGCCTCAGTCTCCCAAGTAG
HSF4 intron 9 HSF4 Mut 1 F TGACTTCTCAGGGTATTCTCCAA 60
HSF4 Mut 1 R TACATGGGCTTTAGGGGTTG
HSF4 intron 9 HSF4 Mut 2 F GATCTGGCAGGATGGTTCAT 60
HSF4 Mut 2 R AGCCACCCTTCCTCTTTGTT
HSF4 intron 9 HSF4 Mut 3 F TAAATTAATTAAAAACAAAGAGGAAGG 60
HSF4 Mut 3 R TGCTCTTGTCTTAACCCACTG
HSF4 intron 9 HSF4 Mut 3.1 F CAGTGGGTTAAGACAAGAGCA 60
HSF4 7.1 R GCTCTGCTTCATCCGTCTCT
Intron 9 insertion LR HSF4 1 F CCCCTTTAGCACTCAGTGGGTTAAGACAAG 62
LR HSF4 1 R GTCCTACCCCAGGCAAAGAGATACTCACT
HSF4 exons 10–12 HSF4 EX10 F CAATAGCAGTTCTTTATGCA 55
HSF4 EX10 R ATTCAGACCGTGATGGCTTC
HSF4 intron 12 HSF4 Intron 12 F TGACGGTCAAGGAGTTGAAT 60
HSF4 Intron 12 R GCCTGGACATCTAGCATGAG
HSF4 exon 13 HSF4 7.6 F GGAACTCTGGGCCTGGAT 60
(RT) HSF4 3 R GGCTTTTTCAGAGGGATGCAG
HSF4 upstream HSF4 PROM 1 F TCCGTCCCCTCTGTACACTC 60
HSF4 PROM 1 R GGGCTCGGAAAGTCCTAGTT
HSF4 5′ cDNA (RT) HSF4 1 F CTTCCTCGGCAAGCTATGG 60
(RT) HSF4 1 R TTGGCTCCTGTACTGCTG
HSF4 mid-cDNA (RT) HSF4 8.1 F GAGTTTCAGCATCCGAGCTT 55
(RT) HSF4 9.1 R CTGTAGCTCCCTTTCCCTTC
HSF4 3′ cDNA (RT) HSF4 7.5 F GAGAGTCTGCTACCCCCAAT 58
HSF4-ET chimeric cDNA HSF4 Intron 12 R GCCTGGACATCTAGCATGAG
Splice 1.1 F GAAGGGAAAGGGAGCTACAG 58
Splice 1.1 R TCTCTGCCATTCTTCAGGTC
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manufacturer's protocol. Reactions were carried out as follows: 94°C (1 min);
35 cycles of 94°C (30 s), 62°C (30 s), 72°C (3 s); final extension 72°C (10 min).
PCR products were electrophoresed on 1% agarose gels, stained with ethidium
bromide, and photographed.
Western blots
Lenses from P21 eyes from C57BL/6 and lop11/lop11 were collected and
protein was extracted following a standard protocol [20]. Forty micrograms of
soluble protein extracts from each C57BL/6 and lop11/lop11 was SDS–PAGE
electrophoresed and blotted as previously described [20]. As a positive control
for Hsf4 protein 5 μg of Jurkat cell lysate (BD Biosciences, San Jose, CA, USA)
was run. The filters were hybridized as previously described [20] with anti-Hsf4
monoclonal antibody (BD Biosciences) at a 1:100 dilution. Membranes werewashed and hybridized with peroxidase-conjugated affinity-purified polyclonal
anti-rabbit IgG (H+L) (Jackson ImmunoResearch Laboratories, West Grove,
PA, USA) at a 1:5000 dilution. To ensure even loading the blots were hybridized
with β-actin monoclonal antibody (Sigma–Aldrich, St. Louis, MO, USA) at a
1:2000 dilution followed by peroxidase-conjugated affinity-purified polyclonal
anti-rabbit IgG (H+L) (Jackson ImmunoResearch Laboratories) at a 1:5000
dilution. The detection was performed using ECL Western blotting detection
reagents (Amersham Biosciences) and a chemiluminescence kit as previously
described [20].
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